Lichen sclerosus can hide behind years of pain and dismissal
For Monica Thomas, the first symptoms began in her teens: intimate itching and soreness that were repeatedly treated as thrush. The pattern is painfully familiar in vulval medicine, where persistent irritation is often minimized, mislabelled, or assumed to be infectious when the real diagnosis lies elsewhere. Her symptoms progressed to sores and blisters, and the pain became so severe that she was bed bound and unable to walk for long periods.
She was examined 28 times in six months before a biopsy was finally offered.
That delay matters because lichen sclerosus is not just a skin condition that causes discomfort. It is a lifelong inflammatory disease of the genital skin that can produce white patches, intense itching, soreness, splitting, and tearing. In women, the condition is most often discussed in the context of menopause and later life, but it can appear at any age, including childhood. It affects men as well, yet the burden in women is especially difficult because symptoms are intimate, visible only to the patient, and still surrounded by embarrassment.
The result is a perfect setup for misdiagnosis. Sexual infections are often considered first, and normal variations in vulval anatomy are rarely discussed in routine care. When symptoms are dismissed early, patients can spend years trying to normalize escalating pain while the underlying inflammation continues unchecked.
Diagnostic delay leaves scarring, pain, and cancer risk in its wake
Dr Nighat Arif, a GP who specialises in women’s health, describes the condition as one that can make sex painful, urination uncomfortable, and everyday movement difficult. The disease is not contagious, is not caused by poor hygiene, and is not an infection. The likely mechanism is autoimmune, with the immune system mistakenly attacking and damaging the skin, although the exact cause remains unknown. Friction or skin trauma can worsen the disease, which helps explain why symptoms often intensify once inflammation has begun.
The problem is not rare enough to be dismissed, but it is rare enough to be overlooked. Analysis by the University of Bristol estimated that vulval lichen sclerosus affects about 1% of women in the West Midlands and Warwickshire, although that figure is almost certainly an underestimate. A long wait for diagnosis and the reality that some patients never seek help at all mean the true prevalence is likely higher.
Dr Sophie Rees, who helped conduct the research, says the combination of shame, embarrassment, and limited clinician awareness keeps many people from being identified in time. She also points to the need for more research into true prevalence. The gap is not academic. If a patient remains untreated for years, the chronic inflammatory process can leave the tissue fragile, scarred, and more vulnerable to complications, including vulval cancer.
A second story shows how long the disease can remain hidden
Clare Baumhaeur’s symptoms began when she was five. She remembers itching and soreness, but no one explained what was happening. Over time, the condition worsened into tears, blisters, and sores, yet she had no way to compare her anatomy with anyone else’s and no reason to believe something dangerous was developing. Even after eight smear tests, nothing was raised.
In 2016, a tear failed to heal. A GP suggested herpes and sent her to a sexual health clinic. She was shocked; she had been married for 25 years. A biopsy eventually confirmed lichen sclerosus and vulval cancer. By then, the cancer had reached stage three.
Her story shows the biological stakes of delayed recognition. Long-standing inflammation can distort the skin, create persistent fissures, and obscure malignant change. By the time a suspicious lesion is biopsied, the opportunity for earlier, less extensive treatment may already have passed. Clare later experienced a cancer recurrence after seven years in remission, then another check-up found pre-cancerous cells, leading to a sixth surgery. Radiotherapy twice left her with early menopause, lymphoedema, and nerve damage.
The emotional burden is part of the disease, not a side issue
Monica describes the period before diagnosis as “horrific” and lonely. The physical symptoms were severe, but the mental toll was deepened by disbelief, repeated alternative diagnoses, and the sense that she had to keep proving that something was wrong. When a patient is told she is too young for a disease that can affect children and adults alike, trust erodes fast. Each missed appointment, each incorrect label, and each dismissive comment adds another layer of harm.
That emotional burden also shapes future care. People who have been embarrassed, disbelieved, or wrongly reassured may delay returning to a doctor even when symptoms worsen. In vulval disease, that hesitation can be costly because changes in the skin should not be watched indefinitely if they are persistent, changing, or ulcerated.
What patients need from clinicians now
Early examination remains the simplest safeguard. Persistent vulval itching, soreness, tearing, whitening, or blistering should not be repeatedly attributed to thrush without a careful genital examination and biopsy when needed. A diagnosis should not end with a prescription alone. Ongoing review matters because the condition can need long-term topical steroid treatment, symptom monitoring, and surveillance for cancerous or pre-cancerous change.
Monica now manages the disease with steroid cream, but she says she does so largely on her own and without the follow-up she believes she should have. Clare’s experience points to the same gap: once the diagnosis finally arrived, the disease had already changed the course of her life. For both women, the central injury was not only the condition itself but the time lost before anyone named it.
Patients who notice vulval changes need language to describe them and clinicians who are willing to listen. A diary of symptoms, photos when appropriate, and repeated requests for review can help when the first appointment ends in dismissal. The deeper clinical problem is simple: lichen sclerosus is visible, treatable, and sometimes dangerous, yet too often it remains hidden behind embarrassment until the damage is already established.